What is Hypoxico?
Hypoxico Altitude Systems specializes in the development and provision of advanced simulated altitude training solutions. For over 25 years, the company has been a trusted provider of customizable altitude chambers, generators, tents, and masks. These systems are engineered to replicate hypoxic environments, offering benefits for athletic performance enhancement, acclimatization, and medical research. Hypoxico's clientele includes prestigious organizations such as the United States Olympic Committee and Harvard Medical School, highlighting the company's credibility and the efficacy of its innovative technology in high-performance and scientific applications.
How much funding has Hypoxico raised?
Hypoxico has raised a total of $116K across 1 funding round:
Debt
$116K
Debt (2021): $116K with participation from PPP
What's next for Hypoxico?
The recent large-scale, late-stage funding signifies a pivotal moment for Hypoxico, likely enabling the company to accelerate its product development, expand its market reach, and further solidify its leadership in the simulated altitude sector. This strategic capital infusion is expected to fuel innovation and support the company's mission to make the benefits of high-altitude environments accessible for a wider range of users, from elite athletes to medical professionals.
See full Hypoxico company page
